The rise of Ozempic in the USA has become a controversial topic as weight loss drugs resurface harmful behaviours and age-old diet culture narratives. Gopuff's attempt to playfully lean into Ozempic conversations highlights how critical people are towards brands referencing sensitive topics.

Weight-loss drugs like Ozempic, Wegovy, and Mounjaro are on the rise in the USA, and many people are interested in seeing how taking them could impact their health. But with drugs like these helping to curb hunger pangs and cut back on cravings, how could they impact food and drink brands?

Oprah Winfrey has publicly admitted to taking the controversial weight loss drug Ozempic following months of public speculation and scrutiny. As weight loss drugs gain mainstream acceptance, people are looking for more transparency around their use in a new era of body positivity.

Zepbound, pharmaceutical company Eli Lilly’s prescription medicine for weight loss, is changing the landscape of weight management. Its effectiveness has triggered a surge in demand against the backdrop of a worldwide obesity epidemic and a significant cultural shift in weight-loss conversations.